Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ArTara Therapeutics, Inc. announces that the company's research and development pipeline is progressing smoothly, and key clinical trials are advancing according to the established schedule.

ArTara Therapeutics, Inc. announces that the company's research and development pipeline is progressing smoothly, and key clinical trials are advancing according to the established schedule.

老虎证券老虎证券2026/02/23 22:37
Show original
It is currently expected that in the second half of 2026, the Advanced-3 phase registration clinical trial for BCG treatment-naïve patient groups will be officially launched. The initiation of this trial is an important milestone in the company's drug development pathway, marking another key step forward for its core candidate product towards potential approval and market launch.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share

Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.

华尔街见闻•2026/11/21 12:01
Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share